Invention Grant
- Patent Title: Pharmaceutical compounds
-
Application No.: US17069070Application Date: 2020-10-13
-
Publication No.: US11319312B2Publication Date: 2022-05-03
- Inventor: Giles Albert Brown , Barry John Teobald , Benjamin Gerald Tehan
- Applicant: Heptares Therapeutics Limited
- Applicant Address: GB Cambridge
- Assignee: Heptares Therapeutics Limited
- Current Assignee: Heptares Therapeutics Limited
- Current Assignee Address: GB Cambridge
- Agency: Fish & Richardson P.C.
- Priority: GB1810245 20180622
- Main IPC: C07D487/10
- IPC: C07D487/10 ; C07D498/08 ; C07D498/10 ; C07D451/02 ; C07D451/14 ; C07D453/06 ; C07D471/10 ; C07D413/14 ; C07D491/08
Abstract:
This invention relates to compounds that are agonists of the muscarinic M1 and/or M4 receptor and which are useful in the treatment of diseases mediated by the muscarinic M1 and M4 receptors. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula where X1; X2; X3; X4; R1 R2 and R4 are as defined herein.
Public/Granted literature
- US20210101893A1 PHARMACEUTICAL COMPOUNDS Public/Granted day:2021-04-08
Information query
